Farydak: Clinical Trials

1 trial of Farydak, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Farydak: new trials by email Literature Review of Farydak trials Research Report on Farydak

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panobinostat Maintenance After HSCT fo High-risk AML and MDS
Panobinostat - Acute Myeloid Leukaemia (AML), Myelodysplastic Syndromes (MDS)
Phase 3TerminatedGoethe University522018-07-242023-02-16

Conditions studied

Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)

Sponsors

Goethe University (1)

Countries

Germany (1)  ·  Netherlands (1)

Top investigators

Gesine Bug, PD Dr. (1)